STAAR Surgical Company Company Profile (NASDAQ:STAA)

About STAAR Surgical Company (NASDAQ:STAA)

STAAR Surgical Company logoSTAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). As of December 30, 2016, it sold its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: Health Care Supplies
  • Symbol: NASDAQ:STAA
  • CUSIP: 85231230
  • Web: www.staar.com
Capitalization:
  • Market Cap: $548.8 million
  • Outstanding Shares: 41,108,000
Average Prices:
  • 50 Day Moving Avg: $12.26
  • 200 Day Moving Avg: $10.67
  • 52 Week Range: $7.45 - $13.95
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 71.32
  • P/E Growth: -4.89
Sales & Book Value:
  • Annual Revenue: $84.48 million
  • Price / Sales: 6.59
  • Book Value: $0.93 per share
  • Price / Book: 14.57
Profitability:
  • EBITDA: ($672,999.00)
  • Net Margins: -6.06%
  • Return on Equity: -8.69%
  • Return on Assets: -5.03%
Debt:
  • Debt-to-Equity Ratio: 0.03%
  • Current Ratio: 2.52%
  • Quick Ratio: 1.81%
Misc:
  • Average Volume: 91,705 shs.
  • Beta: 1.18
  • Short Ratio: 31.08
 

Frequently Asked Questions for STAAR Surgical Company (NASDAQ:STAA)

What is STAAR Surgical Company's stock symbol?

STAAR Surgical Company trades on the NASDAQ under the ticker symbol "STAA."

How were STAAR Surgical Company's earnings last quarter?

STAAR Surgical Company (NASDAQ:STAA) issued its earnings results on Wednesday, August, 2nd. The company reported ($0.01) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.05) by $0.04. The firm had revenue of $21.90 million for the quarter, compared to analyst estimates of $22.15 million. STAAR Surgical Company had a negative return on equity of 8.69% and a negative net margin of 6.06%. The firm's revenue for the quarter was up 4.8% on a year-over-year basis. During the same period last year, the company earned ($0.02) earnings per share. View STAAR Surgical Company's Earnings History.

When will STAAR Surgical Company make its next earnings announcement?

STAAR Surgical Company is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for STAAR Surgical Company.

Where is STAAR Surgical Company's stock going? Where will STAAR Surgical Company's stock price be in 2017?

2 analysts have issued 12-month price objectives for STAAR Surgical Company's shares. Their predictions range from $13.00 to $15.00. On average, they expect STAAR Surgical Company's share price to reach $14.00 in the next twelve months. View Analyst Ratings for STAAR Surgical Company.

Who are some of STAAR Surgical Company's key competitors?

Who are STAAR Surgical Company's key executives?

STAAR Surgical Company's management team includes the folowing people:

  • Caren L. Mason, President, Chief Executive Officer, Director
  • Deborah J. Andrews, Vice President, Interim Chief Financial Officer
  • Hans-Martin Blickensdoerfer, Senior Vice President - Commercial Operations for Europe, Middle East, Africa, Latin America and China.
  • James E. Francese, Senior Vice President of North American and APAC
  • Keith Holliday Ph.D., Chief Technology Officer, Vice President
  • William Walter Goodmen, Vice President - Global Human Resources
  • Jon K. Hayashida, Vice President - Global Clinical and Medical Affairs
  • Philippe Subrin, Vice President-ICL Manufacturing
  • Samuel J. Gesten, Vice President - Business Development, Chief Legal Officer and Secretary
  • Denise McEachern, Global Head of Regulatory Affairs and Quality Assurance

How do I buy STAAR Surgical Company stock?

Shares of STAAR Surgical Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STAAR Surgical Company's stock price today?

One share of STAAR Surgical Company stock can currently be purchased for approximately $13.55.


MarketBeat Community Rating for STAAR Surgical Company (NASDAQ STAA)
Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  93 (Vote Outperform)
Underperform Votes:  177 (Vote Underperform)
Total Votes:  270
MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for STAAR Surgical Company (NASDAQ:STAA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.00 (3.32% upside)
Consensus Price Target History for STAAR Surgical Company (NASDAQ:STAA)
Price Target History for STAAR Surgical Company (NASDAQ:STAA)
Analysts' Ratings History for STAAR Surgical Company (NASDAQ:STAA)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/8/2017Canaccord GenuityReiterated RatingBuy$15.00N/AView Rating Details
8/14/2017Benchmark Co.Boost Price TargetBuy -> Buy$12.00 -> $13.00MediumView Rating Details
8/4/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
5/12/2016StephensDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 10/17/2015 forward)

Earnings

Earnings History for STAAR Surgical Company (NASDAQ:STAA)
Earnings by Quarter for STAAR Surgical Company (NASDAQ:STAA)
Earnings History by Quarter for STAAR Surgical Company (NASDAQ STAA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017($0.04)N/AView Earnings Details
8/2/2017Q2 2017($0.05)($0.01)$22.15 million$21.90 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.05)($0.05)$20.35 millionViewListenView Earnings Details
3/2/2017Q4 2016($0.02)$0.02$22.25 million$22.10 millionViewListenView Earnings Details
11/3/2016Q316($0.04)($0.02)$20.70 million$20.05 millionViewListenView Earnings Details
8/3/2016Q216($0.05)($0.05)$19.88 million$21.00 millionViewListenView Earnings Details
5/11/2016Q116($0.17)($0.01)$19.60 million$19.30 millionViewListenView Earnings Details
3/2/2016Q415($0.02)$0.01$19.11 million$20.90 millionViewListenView Earnings Details
10/28/2015Q315($0.04)($0.04)$17.87 million$18.80 millionViewListenView Earnings Details
4/29/2015Q115($0.04)$0.03$17.85 million$18.90 millionViewListenView Earnings Details
2/25/2015Q414($0.05)($0.03)$16.60 million$16.60 millionViewListenView Earnings Details
10/30/2014Q314$0.02($0.04)$19.53 million$18.20 millionViewListenView Earnings Details
7/30/2014Q214$0.03$0.01$19.80 million$20.05 millionViewListenView Earnings Details
4/28/2014Q114$0.01$0.04$19.44 million$20.20 millionViewListenView Earnings Details
2/26/2014Q413$0.02$0.02$18.98 million$18.90 millionViewListenView Earnings Details
10/30/2013Q313$0.02$0.04$17.35 million$17.10 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.04$0.05$17.40 million$18.20 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.04$0.08$17.27 million$18.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.03$0.01$17.55 million$16.50 millionViewListenView Earnings Details
10/31/2012Q312$0.01$0.04$16.78 million$15.90 millionViewN/AView Earnings Details
8/1/2012$0.03$0.03ViewN/AView Earnings Details
5/2/2012$0.03$0.04ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for STAAR Surgical Company (NASDAQ:STAA)
Current Year EPS Consensus Estimate: $-0.03 EPS
Next Year EPS Consensus Estimate: $0.19 EPS

Dividends

Dividend History for STAAR Surgical Company (NASDAQ:STAA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for STAAR Surgical Company (NASDAQ:STAA)
Insider Ownership Percentage: 3.40%
Institutional Ownership Percentage: 76.54%
Insider Trades by Quarter for STAAR Surgical Company (NASDAQ:STAA)
Institutional Ownership by Quarter for STAAR Surgical Company (NASDAQ:STAA)
Insider Trades by Quarter for STAAR Surgical Company (NASDAQ:STAA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/9/2016Hans-Martin BlickensdoerferVPSell25,000$11.14$278,500.00View SEC Filing  
6/29/2016Broadwood Partners LpMajor ShareholderBuy14,144$5.24$74,114.56View SEC Filing  
5/25/2016Broadwood Partners LpMajor ShareholderBuy77,842$5.16$401,664.72View SEC Filing  
5/24/2016Broadwood Partners LpMajor ShareholderBuy70,000$5.16$361,200.00View SEC Filing  
5/23/2016Broadwood Partners LpMajor ShareholderBuy3,138$5.24$16,443.12View SEC Filing  
5/20/2016Richard A MeierDirectorSell25,000$5.35$133,750.00View SEC Filing  
5/17/2016Broadwood Partners LpMajor ShareholderBuy9,313$5.23$48,706.99View SEC Filing  
5/16/2016Broadwood Partners LpMajor ShareholderBuy336,210$5.49$1,845,792.90View SEC Filing  
2/9/2016Broadwood Partners LpMajor ShareholderBuy91,770$6.25$573,562.50View SEC Filing  
2/3/2016Broadwood Partners LpMajor ShareholderBuy121,599$6.40$778,233.60View SEC Filing  
2/1/2016Broadwood Partners LpMajor ShareholderBuy65,983$6.48$427,569.84View SEC Filing  
1/27/2016Broadwood Partners LpMajor ShareholderBuy239,013$6.63$1,584,656.19View SEC Filing  
1/26/2016Broadwood Partners LpMajor ShareholderBuy112,900$6.60$745,140.00View SEC Filing  
1/25/2016Broadwood Partners LpMajor ShareholderBuy81,752$6.74$551,008.48View SEC Filing  
1/20/2016Broadwood Partners LpMajor ShareholderBuy72,858$6.75$491,791.50View SEC Filing  
1/15/2016Broadwood Partners LpMajor ShareholderBuy135,725$6.73$913,429.25View SEC Filing  
1/11/2016Broadwood Partners LpMajor ShareholderBuy86,586$6.83$591,382.38View SEC Filing  
1/7/2016Broadwood Partners LpMajor ShareholderBuy267,047$6.95$1,855,976.65View SEC Filing  
1/4/2016Broadwood Partners LpMajor ShareholderBuy165,461$7.11$1,176,427.71View SEC Filing  
9/29/2015Broadwood Partners LpMajor ShareholderBuy311,099$7.08$2,202,580.92View SEC Filing  
8/25/2015Broadwood Partners LpMajor ShareholderBuy188,881$7.17$1,354,276.77View SEC Filing  
8/24/2015Caren L MasonCEOBuy10,000$7.34$73,400.00View SEC Filing  
4/6/2015Samuel J GestenVPSell3,223$7.14$23,012.22View SEC Filing  
3/3/2015Robin HughesVPSell23,253$15.82$367,862.46View SEC Filing  
11/19/2014Broadwood Partners LpMajor ShareholderBuy189,646$8.64$1,638,541.44View SEC Filing  
11/18/2014Broadwood Partners LpMajor ShareholderBuy39,400$8.67$341,598.00View SEC Filing  
11/17/2014Broadwood Partners LpMajor ShareholderBuy118,200$8.63$1,020,066.00View SEC Filing  
11/10/2014Broadwood Partners LpMajor ShareholderBuy500$8.79$4,395.00View SEC Filing  
11/7/2014Broadwood Partners LpMajor ShareholderBuy80,000$8.92$713,600.00View SEC Filing  
11/4/2014Broadwood Partners LpMajor ShareholderBuy260,341$9.20$2,395,137.20View SEC Filing  
5/15/2014John MooreDirectorSell2,800$14.87$41,636.00View SEC Filing  
3/19/2014James FranceseVPSell16,666$17.22$286,988.52View SEC Filing  
3/17/2014Robin HughesVPSell5,672$16.61$94,211.92View SEC Filing  
9/4/2013Deborah AndrewsCFOSell50,000$12.88$644,000.00View SEC Filing  
8/20/2013Deborah AndrewsCFOSell33,515$11.65$390,449.75View SEC Filing  
8/12/2013Deborah AndrewsCFOSell9,079$11.62$105,497.98View SEC Filing  
8/7/2013Deborah AndrewsCFOSell11,721$11.79$138,190.59View SEC Filing  
5/9/2013Deborah J AndrewsCFOSell5,000$8.96$44,800.00View SEC Filing  
12/11/2012John C MooreDirectorBuy5,000$5.46$27,300.00View SEC Filing  
11/15/2012Broadwood Partners LpMajor ShareholderBuy2,618$5.00$13,090.00View SEC Filing  
11/15/2012Mark B LoganDirectorBuy3,600$5.22$18,792.00View SEC Filing  
11/14/2012Barry G CaldwellCEOBuy5,000$5.04$25,200.00View SEC Filing  
11/2/2012Broadwood Partners LpMajor ShareholderBuy22,572$5.00$112,860.00View SEC Filing  
8/9/2012Barry G CaldwellCEOBuy5,000$6.57$32,850.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for STAAR Surgical Company (NASDAQ:STAA)
Latest Headlines for STAAR Surgical Company (NASDAQ:STAA)
Source:
DateHeadline
americanbankingnews.com logoZacks Investment Research Lowers STAAR Surgical Company (STAA) to Hold
www.americanbankingnews.com - October 11 at 8:28 PM
thestreet.com logoShort Interest Declines 16.4% For STAA
www.thestreet.com - October 11 at 3:27 PM
americanbankingnews.com logo$0.02 Earnings Per Share Expected for STAAR Surgical Company (STAA) This Quarter
www.americanbankingnews.com - October 11 at 2:16 PM
americanbankingnews.com logoCanaccord Genuity Reaffirms Buy Rating for STAAR Surgical Company (STAA)
www.americanbankingnews.com - October 9 at 2:34 PM
americanbankingnews.com logoSTAAR Surgical (STAA) & The Competition Head-To-Head Review
www.americanbankingnews.com - October 7 at 12:18 AM
finance.yahoo.com logoSTAAR Surgical Appoints Scott D. Barnes, M.D. as Chief Medical Officer
finance.yahoo.com - October 3 at 12:59 PM
americanbankingnews.com logoSTAAR Surgical (STAA) versus Haemonetics Corporation (HAE) Critical Comparison
www.americanbankingnews.com - October 2 at 12:22 AM
prnewswire.com logoSTAAR Surgical Names Deborah Andrews as CFO - PR Newswire (press release)
www.prnewswire.com - September 29 at 7:46 AM
americanbankingnews.com logoDexCom (DXCM) vs. STAAR Surgical (STAA) Head-To-Head Analysis
www.americanbankingnews.com - September 28 at 2:28 PM
bizjournals.com logoSTAAR Surgical Names Deborah Andrews as CFO
www.bizjournals.com - September 28 at 12:05 PM
americanbankingnews.com logoSTAAR Surgical Company (STAA) Upgraded to "Buy" by Canaccord Genuity
www.americanbankingnews.com - September 26 at 12:28 AM
finance.yahoo.com logoETFs with exposure to STAAR Surgical Co. : September 22, 2017
finance.yahoo.com - September 23 at 8:48 AM
americanbankingnews.com logoSTAAR Surgical (STAA) & Bio-Rad Laboratories (BIO) Head-To-Head Contrast
www.americanbankingnews.com - September 16 at 4:42 AM
americanbankingnews.com logoSTAAR Surgical (STAA) & The Competition Head to Head Review
www.americanbankingnews.com - September 12 at 12:28 AM
americanbankingnews.com logoSTAAR Surgical Company (STAA) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - September 10 at 10:10 PM
americanbankingnews.com logoInspireMD (NSPR) & STAAR Surgical (STAA) Head to Head Comparison
www.americanbankingnews.com - September 7 at 4:28 AM
americanbankingnews.com logoTheStreet Upgrades STAAR Surgical Company (STAA) to C
www.americanbankingnews.com - August 17 at 12:26 PM
finance.yahoo.com logoCorporate News Blog - STAAR Surgical Announces Strategic Cooperation Agreement with Seoul/Busan Eye Clinic
finance.yahoo.com - August 17 at 7:58 AM
finance.yahoo.com logoSTAAR Surgical and Seoul/Busan BalGeunSeSang Eye Clinic Announce Strategic Cooperation Agreement
finance.yahoo.com - August 15 at 7:22 AM
americanbankingnews.com logoSTAAR Surgical Company (NASDAQ:STAA) Price Target Raised to $13.00 at Benchmark Co.
www.americanbankingnews.com - August 14 at 8:36 AM
americanbankingnews.com logo Brokerages Set $11.67 Target Price for STAAR Surgical Company (STAA)
www.americanbankingnews.com - August 11 at 11:14 PM
americanbankingnews.com logoSTAAR Surgical (STAA) versus OraSure Technologies (OSUR) Head-To-Head Comparison
www.americanbankingnews.com - August 6 at 2:22 PM
americanbankingnews.com logoSTAAR Surgical Company (NASDAQ:STAA) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS
www.americanbankingnews.com - August 3 at 9:21 PM
americanbankingnews.com logoSTAAR Surgical Company (NASDAQ:STAA) Price Target Increased to $11.00 by Analysts at Canaccord Genuity
www.americanbankingnews.com - August 3 at 6:06 PM
seekingalpha.com logoSTAAR's (STAA) CEO Caren Mason on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 3 at 7:34 AM
rttnews.com logoEARNINGS SUMMARY: Details of STAAR Surgical Company Q2 Earnings Report
www.rttnews.com - August 3 at 7:34 AM
finance.yahoo.com logoSTAAR Surgical Reports Second Quarter 2017 Results
finance.yahoo.com - August 3 at 7:34 AM
finance.yahoo.com logoEdited Transcript of STAA earnings conference call or presentation 2-Aug-17 8:30pm GMT
finance.yahoo.com - August 3 at 7:34 AM
finance.yahoo.com logoStaar Surgical reports 2Q loss
finance.yahoo.com - August 3 at 7:34 AM
americanbankingnews.com logoCritical Comparison: STAAR Surgical (STAA) versus OraSure Technologies (OSUR)
www.americanbankingnews.com - July 31 at 9:32 AM
americanbankingnews.com logoSTAAR Surgical Company (STAA) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 27 at 4:09 PM
finance.yahoo.com logoSTAAR Surgical to Report Second Quarter Results on August 2, 2017
finance.yahoo.com - July 20 at 8:08 AM
reuters.com logoStaar Surgical to pay $7 million in investor suit over FDA violations
www.reuters.com - June 22 at 1:50 PM
rttnews.com logoEARNINGS SUMMARY: Details of STAAR Surgical Company Q1 Earnings Report
www.rttnews.com - May 3 at 6:12 PM
reuters.com logoBRIEF-Staar Surgical reports Q1 sales $20.4 million
www.reuters.com - May 3 at 6:12 PM
wsj.com logoCFO Moves: Varian Medical Systems, STAAR Surgical, Federated National Holding, Daily Mail & General Trust
blogs.wsj.com - April 7 at 12:48 PM
biz.yahoo.com logoSTAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - March 3 at 8:01 PM
seekingalpha.com logoSTAAR Surgical's (STAA) CEO Caren Mason on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 2 at 8:08 PM
nasdaq.com logoSTAAR Surgical Company Q4 Income Climbs 46%
www.nasdaq.com - March 2 at 8:08 PM
reuters.com logoBRIEF-Staar Surgical Q4 adjusted earnings per share $0.02
www.reuters.com - March 2 at 8:08 PM
biz.yahoo.com logoQ4 2016 STAAR Surgical Co Earnings Release - After Market Close
us.rd.yahoo.com - March 2 at 8:08 PM
us.rd.yahoo.com logoSTAAR Surgical Reports Fourth Quarter 2016 Results
us.rd.yahoo.com - March 2 at 8:08 PM
us.rd.yahoo.com logo4:04 pm STAAR Surgical reports EPS in-line, revs in-line
us.rd.yahoo.com - March 2 at 8:08 PM
biz.yahoo.com logoSTAAR SURGICAL CO Files SEC form 8-K, Results of Operations and Financial Condition
us.rd.yahoo.com - March 2 at 8:08 PM
businesswire.com logoNorth America Ophthalmology Cataract Surgery Devices Market - Opportunities and Forecasts, 2014 - 2022 - Research and Markets
www.businesswire.com - February 22 at 10:05 AM
streetinsider.com logoForm 8-K STAAR SURGICAL CO For: Jan 10
www.streetinsider.com - January 12 at 1:24 AM

Social

Chart

STAAR Surgical Company (STAA) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.